SEK155.90
2.32% today
Stockholm, Dec 30, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS
Sector

Surgical Science Sweden AB Target price 2024 - Analyst rating & recommendation

Surgical Science Sweden AB Classifications & Recommendation:

Buy
100%

Surgical Science Sweden AB Price Target

Target Price SEK189.60
Price SEK155.90
Potential
Number of Estimates 5
5 Analysts have issued a price target Surgical Science Sweden AB 2025 . The average Surgical Science Sweden AB target price is SEK189.60. This is higher than the current stock price. The highest price target is
SEK225.00 44.32%
register free of charge
, the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Surgical Science Sweden AB to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Surgical Science Sweden AB stock has an average upside potential 2025 of . Most analysts recommend the Surgical Science Sweden AB stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million SEK 882.85 898.60
10.01% 1.78%
EBITDA Margin 27.97% 25.53%
8.69% 8.71%
Net Margin 26.53% 16.01%
12.77% 39.66%

5 Analysts have issued a sales forecast Surgical Science Sweden AB 2024 . The average Surgical Science Sweden AB sales estimate is

SEK899m
Unlock
. This is
4.51% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK914m 6.32%
Unlock
, the lowest is
SEK888m 3.22%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 SEK883m 10.01%
2024
SEK899m 1.78%
Unlock
2025
SEK1.1b 21.96%
Unlock
2026
SEK1.3b 18.90%
Unlock

5 Analysts have issued an Surgical Science Sweden AB EBITDA forecast 2024. The average Surgical Science Sweden AB EBITDA estimate is

SEK229m
Unlock
. This is
6.48% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
SEK238m 10.66%
Unlock
, the lowest is
SEK222m 3.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 SEK247m 19.57%
2024
SEK229m 7.07%
Unlock
2025
SEK369m 60.76%
Unlock
2026
SEK505m 37.01%
Unlock

EBITDA Margin

2023 27.97% 8.69%
2024
25.53% 8.71%
Unlock
2025
33.65% 31.81%
Unlock
2026
38.78% 15.25%
Unlock

4 Surgical Science Sweden AB Analysts have issued a net profit forecast 2024. The average Surgical Science Sweden AB net profit estimate is

SEK144m
Unlock
. This is
25.62% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK147m 23.79%
Unlock
, the lowest is
SEK139m 27.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 SEK234m 24.05%
2024
SEK144m 38.58%
Unlock
2025
SEK252m 74.99%
Unlock
2026
SEK349m 38.74%
Unlock

Net Margin

2023 26.53% 12.77%
2024
16.01% 39.66%
Unlock
2025
22.97% 43.47%
Unlock
2026
26.80% 16.67%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share SEK 4.59 2.82
24.05% 38.56%
P/E 56.61
EV/Sales 8.32

4 Analysts have issued a Surgical Science Sweden AB forecast for earnings per share. The average Surgical Science Sweden AB <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

SEK2.82
Unlock
. This is
25.59% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
SEK2.89 23.75%
Unlock
, the lowest is
SEK2.73 27.97%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 SEK4.59 24.05%
2024
SEK2.82 38.56%
Unlock
2025
SEK4.93 74.82%
Unlock
2026
SEK6.84 38.74%
Unlock

P/E ratio

Current 42.12 17.46%
2024
56.61 34.40%
Unlock
2025
32.35 42.85%
Unlock
2026
23.32 27.91%
Unlock

Based on analysts' sales estimates for 2024, the Surgical Science Sweden AB stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.70
2024
8.32 4.35%
Unlock
2025
6.82 18.01%
Unlock
2026
5.74 15.90%
Unlock

P/S ratio

Current 9.47 5.61%
2024
9.06 4.32%
Unlock
2025
7.43 18.01%
Unlock
2026
6.25 15.90%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today